STIPE Therapeutics ApS — Credit Rating and Financial Key Figures

STIPE Therapeutics ApS (CVR number: 39691175) is a company from KØBENHAVN. The company recorded a gross profit of -842.3 kEUR in 2024. The operating profit was -1499.8 kEUR, while net earnings were 1448.7 kEUR. The profitability of the company measured by Return on Assets (ROA) was 50.9 %, which can be considered excellent and Return on Equity (ROE) was 67.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 96.8 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. STIPE Therapeutics ApS's liquidity measured by quick ratio was 31.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.